Regenxbio (RGNX) Accounts Payables (2014 - 2026)
Regenxbio (RGNX) posted quarterly Accounts Payables of $21.4 million for Q4 2025, down 6.32% year-over-year from $22.8 million in Q4 2024, and down 4.08% quarter-over-quarter from $22.3 million in Q3 2025.
Regenxbio (RGNX) Accounts Payables (2014 - 2026) Analysis & Trends
Regenxbio's Accounts Payables history runs 12 years deep, the most recent figure standing at $21.4 million for Q4 2025.
- In Q4 2025, Accounts Payables fell 6.32% year-over-year to $21.4 million; the TTM figure through Dec 2025 stood at $21.4 million (down 6.32% YoY), while the FY2025 annual figure was $21.4 million, down 6.32% from the prior year.
- Accounts Payables for Q4 2025 stood at $21.4 million, down from $22.3 million in the prior quarter.
- The five-year high for Accounts Payables was $31.4 million in Q1 2024, with the low at $9.4 million in Q2 2021.
- The 5-year median for Accounts Payables is $21.5 million (2025), against an average of $20.0 million.
- The sharpest annual moves came in 2022 and 2025: Accounts Payables jumped 138.98% in 2022, then sank 39.27% in 2025.
- Regenxbio's Accounts Payables stood at $11.4 million in 2021, then soared by 138.98% to $27.2 million in 2022, then decreased by 16.27% to $22.8 million in 2023, then increased by 0.05% to $22.8 million in 2024, then dropped by 6.32% to $21.4 million in 2025.
- Business Quant data shows RGNX's Accounts Payables at $21.4 million in Q4 2025, $22.3 million in Q3 2025, and $21.7 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.52 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 88.42 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 470.30 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3.05 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 35.57 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 108.02 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 428.93 Mn |
| 10 | Regenxbio | 583.35 Mn | 477.83 Mn | 106.98 Mn | 15.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 15.55 Mn |
| Dec 31, 2025 | 21.36 Mn |
| Sep 30, 2025 | 22.27 Mn |
| Jun 30, 2025 | 21.66 Mn |
| Mar 31, 2025 | 19.04 Mn |
| Dec 31, 2024 | 22.80 Mn |
| Sep 30, 2024 | 19.52 Mn |
| Jun 30, 2024 | 16.36 Mn |
| Mar 31, 2024 | 31.36 Mn |
| Dec 31, 2023 | 22.79 Mn |
| Sep 30, 2023 | 21.86 Mn |
| Jun 30, 2023 | 11.64 Mn |
| Mar 31, 2023 | 23.28 Mn |
| Dec 31, 2022 | 27.21 Mn |
| Sep 30, 2022 | 25.21 Mn |
| Jun 30, 2022 | 16.99 Mn |
| Mar 31, 2022 | 24.71 Mn |
| Dec 31, 2021 | 11.39 Mn |
| Sep 30, 2021 | 19.85 Mn |
| Jun 30, 2021 | 9.35 Mn |